D-0529-2025 Class III Ongoing

Recalled by AvKARE — Pulaski, TN

FDA drug recall D-0529-2025 was initiated by AvKARE on Jun 26, 2025 and is designated Class III. Reason for recall: Failed Impurity/Degradation Specifications The recall status is ongoing. Affected quantity: 8,573 bottles.

Recall details

Product Type
Drugs
Report Date
Jul 9, 2025
Initiation Date
Jun 26, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
8,573 bottles

Product description

Pitavastatin Tablets, 2 mg, 90 Tablets per bottle, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478. NDC: 42291-906-90

Reason for recall

Failed Impurity/Degradation Specifications

Distribution pattern

Nationwide in the USA

Code information

Lot, expiry: Lot 46211, exp 10/31/2025; Lot 47683, exp 05/31/2026; Lot 46944 , exp 01/31/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0529-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0529-2025. Report a data issue: hello@regdatalab.com.